You have 9 free searches left this month | for more free features.

objective response rate

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Objective Response Rate Trial in Wuhan (GM-CSF)

Recruiting
  • Objective Response Rate
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Feb 25, 2023

Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))

Recruiting
  • Advanced Breast Cancer
  • +2 more
  • Trastuzumab Emtansine (T-DM1)
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023

Objective Response Rate (ORR) Trial (Envafolimab, Lenvatinib Combined With TACE)

Not yet recruiting
  • Objective Response Rate (ORR)
  • Envafolimab, Lenvatinib Combined With TACE
  • (no location specified)
Oct 13, 2022

Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

Recruiting
  • Breast Cancer Stage IV
  • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
  • Mansoura, Dakahlia, Egypt
    Oncology center mansoura university
Jan 1, 2023

Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)

Completed
  • Cancer
  • Melanoma
  • Guangzhou, Guangdong, China
  • +12 more
Jan 4, 2022

Recurrent Cervical Carcinoma, Metastatic Cervical Carcinoma, Persistent Cervical Carcinoma Trial in Beijing (Tislelizumab plus

Recruiting
  • Recurrent Cervical Carcinoma
  • +9 more
  • Tislelizumab plus radiotherapy
  • Beijing, Beijing, China
    Lei Li
Apr 1, 2022

Fasting Mimicking Diet, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Netherlands (Fasting

Not yet recruiting
  • Fasting Mimicking Diet
  • +5 more
  • Fasting Mimicking diet program
  • Alkmaar, Netherlands
  • +14 more
Aug 15, 2022

Objective Response Rate Trial in Jinan (albumin-bound paclitaxe combined with bevacizumab biosimilar)

Recruiting
  • Objective Response Rate
  • albumin-bound paclitaxe combined with bevacizumab biosimilar
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Oct 7, 2021

Objective Response Rate Trial in Hangzhou (CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine)

Recruiting
  • Objective Response Rate
  • CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 5, 2021

Recurrent Cervical Carcinoma, Radiotherapy, Epidermal Growth Factor Receptor Trial in Beijing (Combination of nimotuzumab and

Recruiting
  • Recurrent Cervical Carcinoma
  • +6 more
  • Combination of nimotuzumab and radiotherapy
  • Beijing, Beijing, China
    Lei Li
Dec 18, 2020

Heart Failure, ICD, Chronotropic Incompetence Trial in La Jolla (CLS Mode on Biotronik CRT-D, Accelerometer Mode on Biotronik

Completed
  • Heart Failure
  • +2 more
  • CLS Mode on Biotronik CRT-D
  • Accelerometer Mode on Biotronik CRT-D
  • La Jolla, California
    Sulpizio Cardiovascular Center
Jul 14, 2021

Chemo, Anti-pd-1 Antibody, Cervical Neuroendocrine Carcinoma Trial in Beijing (Drug therapy)

Recruiting
  • Chemotherapy
  • +6 more
  • Drug therapy
  • Beijing, Beijing, China
    Lei Li
Nov 15, 2020

Unresected Stage IIIb to IVM1c Melanoma Trial in Worldwide (Talimogene Laherparepvec)

Completed
  • Unresected Stage IIIb to IVM1c Melanoma
  • Talimogene Laherparepvec
  • Salt Lake City, Utah
  • +41 more
Nov 26, 2021

Objective Structured Clinical Examination on Stress Among

Recruiting
  • Heart Rate Variability
  • +2 more
    • Clermont-Ferrand, Auvergne-Rhone-Alpes, France
    • +1 more
    Nov 14, 2023

    Response Rate in Patients With Advanced NSCLC on ICI

    Recruiting
    • Non Small Cell Lung Cancer Metastatic
    • Diabetes Mellitus
    • Pembrolizumab
    • Assiut, Egypt
      Assiut university
    Oct 20, 2023

    Anesthesia, Pain, Acute Trial in Gothenburg (NoL)

    Recruiting
    • Anesthesia
    • Pain, Acute
    • NoL
    • Gothenburg, Sweden
      Sahlgrenska University hospital
    Jan 11, 2022

    Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

    Completed
    • Objective Response
    • Overall Survival
    • VIA combination treatment
    • Beijing, China
      Peking University People's Hospital
    Dec 9, 2022

    Chronic Stroke, Weakness, Muscle Trial in Nashville (Average Force Production)

    Recruiting
    • Chronic Stroke
    • Weakness, Muscle
    • Average Force Production
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 11, 2023

    Correlating Heart Rate Variability and Chronic Pain

    Recruiting
    • Chronic Pain
    • Questionnaires, physical tests, and heart rate variability measures
    • Ottawa, Ontario, Canada
      Canadian Forces Health Services Centre
    Jul 19, 2022

    Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Guangzhou (drug, radiation, procedure, other)

    Recruiting
    • Rectal Cancer
    • +3 more
    • Capecitabine, Oxaliplatin
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 19, 2022

    Breathing Maneuvers for Inducible Myocardial Perfusion Deficits

    Recruiting
    • Coronary Artery Disease, Hyperventilation, Breath-hold, Pulse Rate
    • 4 minute breathing maneuver
    • Montréal, Quebec, Canada
      The Research Institute of the McGill University Health Center
    Aug 23, 2022

    Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

    Not yet recruiting
    • Thrombopoietin Receptor Agonist
      • (no location specified)
      May 4, 2023

      Infertility, Female, PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries Trial (metformin)

      Not yet recruiting
      • Infertility, Female
      • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
      • (no location specified)
      Mar 2, 2023

      "Online Surveys" in Perioperative Knee Anterior Cruciate

      Not yet recruiting
      • Anterior Cruciate Ligament Rupture
      • knee brace cold therapy
      • (no location specified)
      Jun 14, 2022

      Autonomic Dysfunction, Inflammatory Response, Chronic Kidney Diseases Trial in Taipei (heart rate variability biofeedback)

      Recruiting
      • Autonomic Dysfunction
      • +2 more
      • heart rate variability biofeedback
      • Taipei, Taiwan
        Tri-Service Medical Center
      Sep 26, 2022